• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

贝叶烷酸衍生物作为抗肿瘤剂的三维 QSAR 研究:拓扑 CoMFA 模型构建研究与实验验证。

A 3D QSAR study of betulinic acid derivatives as anti-tumor agents using topomer CoMFA: model building studies and experimental verification.

机构信息

Alkali Soil Natural Environmental Science Center, Northeast Forestry University/Key Laboratory of Saline-Alkali Vegetation Ecology Restoration in Oil Field, Ministry of Education, Harbin 150040, China.

出版信息

Molecules. 2013 Aug 22;18(9):10228-41. doi: 10.3390/molecules180910228.

DOI:10.3390/molecules180910228
PMID:23973995
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6270193/
Abstract

Betulinic acid (BA) is a natural product that exerts its cytotoxicity against various malignant carcinomas without side effects by triggering the mitochondrial pathway to apoptosis. Betulin (BE), the 28-hydroxyl analog of BA, is present in large amounts (up to 30% dry weight) in the outer bark of birch trees, and shares the same pentacyclic triterpenoid core as BA, yet exhibits no significant cytotoxicity. Topomer CoMFA studies were performed on 37 BA and BE derivatives and their in vitro anti-cancer activity results (reported as IC₅₀ values) against HT29 human colon cancer cells in the present study. All derivatives share a common pentacyclic triterpenoid core and the molecules were split into three pieces by cutting at the C-3 and C-28 sites with a consideration toward structural diversity. The analysis gave a leave-one-out cross-validation q² value of 0.722 and a non-cross-validation r² value of 0.974, which suggested that the model has good predictive ability (q² > 0.2). The contour maps illustrated that bulky and electron-donating groups would be favorable for activity at the C-28 site, and a moderately bulky and electron-withdrawing group near the C-3 site would improve this activity. BE derivatives were designed and synthesized according to the modeling result, whereby bulky electronegative groups (maleyl, phthalyl, and hexahydrophthalyl groups) were directly introduced at the C-28 position of BE. The in vitro cytotoxicity values of the given analogs against HT29 cells were consistent with the predicted values, proving that the present topomer CoMFA model is successful and that it could potentially guide the synthesis of new betulinic acid derivatives with high anti-cancer activity. The IC₅₀ values of these three new compounds were also assayed in five other tumor cell lines. 28-O-hexahydrophthalyl BE exhibited the greatest anti-cancer activities and its IC₅₀ values were lower than those of BA in all cell lines, excluding DU145 cells.

摘要

桦木酸(BA)是一种天然产物,通过触发线粒体凋亡途径,对各种恶性癌没有副作用地发挥细胞毒性。白桦脂(BE)是 BA 的 28-羟基类似物,大量存在于桦木的外树皮中(高达干重的 30%),与 BA 具有相同的五环三萜核心,但没有表现出显著的细胞毒性。对 37 种 BA 和 BE 衍生物及其在本研究中针对 HT29 人结肠癌细胞的体外抗癌活性结果(报告为 IC₅₀ 值)进行了拓扑构象 CoMFA 研究。所有衍生物都有一个共同的五环三萜核心,并且分子通过在 C-3 和 C-28 位点切割,考虑到结构多样性,被分为三个部分。分析得到的留一法交叉验证 q² 值为 0.722,非交叉验证 r² 值为 0.974,这表明该模型具有良好的预测能力(q²>0.2)。等高线图表明,在 C-28 位上,大的给电子基团是有利的,而在 C-3 位附近有一个适度大的吸电子基团会提高这种活性。根据建模结果设计并合成了 BE 衍生物,其中在 BE 的 C-28 位直接引入了大的电负性基团(马来酰基、邻苯二甲酰基和六氢邻苯二甲酰基)。所给类似物对 HT29 细胞的体外细胞毒性值与预测值一致,证明了本拓扑构象 CoMFA 模型是成功的,并且它可能指导具有高抗癌活性的新型桦木酸衍生物的合成。还在另外五个肿瘤细胞系中测定了这三种新化合物的 IC₅₀ 值。28-O-六氢邻苯二甲酰基 BE 表现出最大的抗癌活性,其 IC₅₀ 值在所有细胞系中均低于 BA,除 DU145 细胞外。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1027/6270193/5f1588095495/molecules-18-10228-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1027/6270193/80fb26ba036e/molecules-18-10228-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1027/6270193/854c228012f2/molecules-18-10228-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1027/6270193/f94959b4833c/molecules-18-10228-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1027/6270193/6818a11869d7/molecules-18-10228-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1027/6270193/707b8794f045/molecules-18-10228-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1027/6270193/5f1588095495/molecules-18-10228-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1027/6270193/80fb26ba036e/molecules-18-10228-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1027/6270193/854c228012f2/molecules-18-10228-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1027/6270193/f94959b4833c/molecules-18-10228-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1027/6270193/6818a11869d7/molecules-18-10228-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1027/6270193/707b8794f045/molecules-18-10228-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1027/6270193/5f1588095495/molecules-18-10228-g006.jpg

相似文献

1
A 3D QSAR study of betulinic acid derivatives as anti-tumor agents using topomer CoMFA: model building studies and experimental verification.贝叶烷酸衍生物作为抗肿瘤剂的三维 QSAR 研究:拓扑 CoMFA 模型构建研究与实验验证。
Molecules. 2013 Aug 22;18(9):10228-41. doi: 10.3390/molecules180910228.
2
A 3D-QSAR Study on Betulinic Acid Derivatives as Anti-Tumor Agents and the Synthesis of Novel Derivatives for Modeling Validation.桦木酸衍生物作为抗肿瘤药物的3D-QSAR研究及用于模型验证的新型衍生物的合成
Anticancer Agents Med Chem. 2017;17(4):566-575. doi: 10.2174/1871520616666160922101712.
3
Betulinic Acid and its Derivatives as Potential Antitumor Agents.白桦脂酸及其衍生物作为潜在的抗肿瘤药物。
Med Res Rev. 2015 Nov;35(6):1127-55. doi: 10.1002/med.21353. Epub 2015 Jun 2.
4
Novel semisynthetic derivatives of betulin and betulinic acid with cytotoxic activity.具有细胞毒性活性的桦木醇和桦木酸新型半合成衍生物。
Bioorg Med Chem. 2009 Sep 1;17(17):6241-50. doi: 10.1016/j.bmc.2009.07.050. Epub 2009 Jul 25.
5
Understanding the structure-activity relationship of betulinic acid derivatives as anti-HIV-1 agents by using 3D-QSAR and docking.通过使用 3D-QSAR 和对接研究桦木酸衍生物作为抗 HIV-1 药物的构效关系。
J Mol Model. 2011 Jul;17(7):1643-59. doi: 10.1007/s00894-010-0870-x. Epub 2010 Oct 27.
6
Synthesis and cytotoxicity of triterpenoids derived from betulin and betulinic acid via click chemistry.通过点击化学法由桦木醇和桦木酸衍生的三萜类化合物的合成及其细胞毒性
J Asian Nat Prod Res. 2015;17(2):159-69. doi: 10.1080/10286020.2014.979164. Epub 2014 Nov 7.
7
New ionic derivatives of betulinic acid as highly potent anti-cancer agents.桦木酸新型离子衍生物作为高效抗癌药物。
Bioorg Med Chem Lett. 2012 Feb 15;22(4):1734-8. doi: 10.1016/j.bmcl.2011.12.102. Epub 2011 Dec 28.
8
Lupane triterpenoids--betulin and betulinic acid derivatives induce apoptosis in tumor cells.羽扇豆烷三萜类化合物——白桦脂醇和白桦脂酸衍生物诱导肿瘤细胞凋亡。
Invest New Drugs. 2011 Apr;29(2):266-72. doi: 10.1007/s10637-009-9358-x. Epub 2009 Dec 4.
9
Synthesis and structure-activity relationship study of novel cytotoxic carbamate and N-acylheterocyclic bearing derivatives of betulin and betulinic acid.新型具有细胞毒性的氨甲酰基和 N-酰基杂环取代的桦木醇和白桦脂酸衍生物的合成及构效关系研究。
Bioorg Med Chem. 2010 Jun 15;18(12):4385-96. doi: 10.1016/j.bmc.2010.04.085. Epub 2010 Apr 29.
10
Cytotoxic Potential of Betulinic Acid Fatty Esters and Their Liposomal Formulations: Targeting Breast, Colon, and Lung Cancer Cell Lines.白桦脂酸脂肪酸酯及其脂质体制剂的细胞毒性:针对乳腺癌、结肠癌和肺癌细胞系。
Molecules. 2024 Jul 19;29(14):3399. doi: 10.3390/molecules29143399.

引用本文的文献

1
A Novel Betulinic Acid Analogue: Synthesis, Solubility, Antitumor Activity and Pharmacokinetic Study in Rats.一种新型白桦脂酸类似物的合成、溶解度、抗肿瘤活性及在大鼠体内的药代动力学研究。
Molecules. 2023 Jul 28;28(15):5715. doi: 10.3390/molecules28155715.
2
Structural modification of 4, 5-dihydro-[1, 2, 4] triazolo [4, 3-f] pteridine derivatives as BRD4 inhibitors using 2D/3D-QSAR and molecular docking analysis.使用二维/三维定量构效关系和分子对接分析对 4,5-二氢-[1,2,4]三唑并[4,3-f]蝶啶衍生物进行结构修饰作为 BRD4 抑制剂。
Mol Divers. 2021 Aug;25(3):1855-1872. doi: 10.1007/s11030-020-10172-5. Epub 2021 Jan 3.
3
Predictive classification models and targets identification for betulin derivatives as Leishmania donovani inhibitors.

本文引用的文献

1
Development and validation of a RP-HPLC method with fluorescence detection for simultaneous determination of 10-methoxycamptothecin and its metabolite 10-hydroxycamptothecin in rat plasma.建立并验证了一种反相高效液相色谱-荧光检测法,用于同时测定大鼠血浆中的 10-甲氧基喜树碱及其代谢物 10-羟基喜树碱。
J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Aug 15;903:81-7. doi: 10.1016/j.jchromb.2012.07.001. Epub 2012 Jul 11.
2
R-group template CoMFA combines benefits of "ad hoc" and topomer alignments using 3D-QSAR for lead optimization.R 基团模板 CoMFA 通过使用 3D-QSAR 进行先导优化,结合了“特定”和拓扑构象对齐的优势。
J Comput Aided Mol Des. 2012 Jul;26(7):805-19. doi: 10.1007/s10822-012-9583-9. Epub 2012 Jun 4.
3
作为杜氏利什曼原虫抑制剂的桦木醇衍生物的预测分类模型及靶点鉴定
J Cheminform. 2018 Aug 17;10(1):40. doi: 10.1186/s13321-018-0291-x.
4
Design, synthesis, crystal structure and fungicidal activity of ()-5-(methoxyimino)-3,5-dihydrobenzo[][1,2]oxazepin-4(1)-one analogues.()-5-(甲氧基亚氨基)-3,5-二氢苯并[][1,2]噁氮杂卓-4(1)-酮类似物的设计、合成、晶体结构及杀菌活性
Medchemcomm. 2017 Mar 8;8(5):1007-1014. doi: 10.1039/c7md00025a. eCollection 2017 May 1.
5
2D-QSAR and 3D-QSAR Analyses for EGFR Inhibitors.二维定量构效关系(2D-QSAR)和三维定量构效关系(3D-QSAR)分析用于表皮生长因子受体抑制剂。
Biomed Res Int. 2017;2017:4649191. doi: 10.1155/2017/4649191. Epub 2017 May 29.
6
Comparative Study of Green Sub- and Supercritical Processes to Obtain Carnosic Acid and Carnosol-Enriched Rosemary Extracts with in Vitro Anti-Proliferative Activity on Colon Cancer Cells.绿色亚临界和超临界过程制备富含鼠尾草酸和鼠尾草酚的迷迭香提取物及其对结肠癌细胞体外抗增殖活性的比较研究
Int J Mol Sci. 2016 Dec 7;17(12):2046. doi: 10.3390/ijms17122046.
7
Recent studies on betulinic acid and its biological and pharmacological activity.关于桦木酸及其生物学和药理学活性的近期研究。
EXCLI J. 2015 Feb 2;14:199-203. doi: 10.17179/excli2015-150. eCollection 2015.
8
Synthesis, Antifungal Activity and Structure-Activity Relationships of Novel 3-(Difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylic Acid Amides.新型3-(二氟甲基)-1-甲基-1H-吡唑-4-羧酸酰胺的合成、抗真菌活性及构效关系
Molecules. 2015 May 8;20(5):8395-408. doi: 10.3390/molecules20058395.
9
Combined pharmacophore modeling, 3D-QSAR, homology modeling and docking studies on CYP11B1 inhibitors.细胞色素P450 11B1抑制剂的联合药效团建模、三维定量构效关系、同源建模及对接研究
Molecules. 2015 Jan 9;20(1):1014-30. doi: 10.3390/molecules20011014.
10
Cardioprotective effect of betulinic Acid on myocardial ischemia reperfusion injury in rats.白桦脂酸对大鼠心肌缺血再灌注损伤的心脏保护作用。
Evid Based Complement Alternat Med. 2014;2014:573745. doi: 10.1155/2014/573745. Epub 2014 May 21.
New betulinic acid derivatives induce potent and selective antiproliferative activity through cell cycle arrest at the S phase and caspase dependent apoptosis in human cancer cells.
新型白桦脂酸衍生物通过细胞周期阻滞在 S 期和 caspase 依赖性细胞凋亡诱导人癌细胞强烈且选择性的增殖抑制活性。
Biochimie. 2011 Jun;93(6):1065-75. doi: 10.1016/j.biochi.2011.02.014. Epub 2011 Mar 4.
4
Synthesis, cytotoxicity and liposome preparation of 28-acetylenic betulin derivatives.28-炔基白桦脂衍生物的合成、细胞毒性及脂质体的制备。
Bioorg Med Chem. 2010 Oct 15;18(20):7252-9. doi: 10.1016/j.bmc.2010.08.023. Epub 2010 Aug 26.
5
Inhibitory effect of the natural product betulin and its derivatives against the intracellular bacterium Chlamydia pneumoniae.天然产物白桦脂醇及其衍生物对细胞内细菌肺炎衣原体的抑制作用。
Biochem Pharmacol. 2010 Oct 15;80(8):1141-51. doi: 10.1016/j.bcp.2010.06.051. Epub 2010 Jul 6.
6
Synthesis and structure-activity relationship study of novel cytotoxic carbamate and N-acylheterocyclic bearing derivatives of betulin and betulinic acid.新型具有细胞毒性的氨甲酰基和 N-酰基杂环取代的桦木醇和白桦脂酸衍生物的合成及构效关系研究。
Bioorg Med Chem. 2010 Jun 15;18(12):4385-96. doi: 10.1016/j.bmc.2010.04.085. Epub 2010 Apr 29.
7
Small structural changes of pentacyclic lupane type triterpenoid derivatives lead to significant differences in their anticancer properties.五环三萜类衍生物的微小结构变化会导致其抗癌性能的显著差异。
Eur J Med Chem. 2010 Aug;45(8):3346-53. doi: 10.1016/j.ejmech.2010.04.018. Epub 2010 Apr 27.
8
Carbamate derivatives of betulinic acid and betulin with selective cytotoxic activity.桦木酸和白桦脂醇的氨基甲酸酯衍生物具有选择性细胞毒性。
Bioorg Med Chem Lett. 2010 Jun 1;20(11):3409-12. doi: 10.1016/j.bmcl.2010.04.004. Epub 2010 Apr 18.
9
Synthesis and biological evaluation of antitumor-active gamma-butyrolactone substituted betulin derivatives.合成及抗肿瘤活性的γ-丁内酯取代白桦脂烷衍生物的生物评价。
Bioorg Med Chem. 2010 Apr 1;18(7):2549-58. doi: 10.1016/j.bmc.2010.02.042. Epub 2010 Mar 2.
10
In vitro anticancer studies of alpha- and beta-D-glucopyranose betulin anomers.α-和β-D-吡喃葡萄糖桦脂醇糖苷异构体的体外抗癌研究。
Chem Biol Interact. 2010 Apr 29;185(2):128-36. doi: 10.1016/j.cbi.2010.02.038. Epub 2010 Mar 1.